Biocerta Precision Diagnostics, Inc.
PrivateLast Round
Corporate Funding
Dec 17, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biocerta Precision Diagnostics, Inc. operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Corporate Funding round in December 2025.
Biocerta Precision Diagnostics, Inc. is a biotechnology company that has developed a functional drug-sensitivity platform to guide personalized cancer treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocerta Precision Diagnostics, Inc. Comparables
Compare Biocerta Precision Diagnostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SageMedic Corp. | 88% | |
| Travera | 87% | |
| Nagourney Cancer Institute | 83% |
For institutional investors. Book with your work email.
Biocerta Precision Diagnostics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 17, 2025 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Completed a corporate funding round.
For institutional investors. Book with your work email.
Biocerta Precision Diagnostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biocerta Precision Diagnostics, Inc.'s valuation, stock price, and market status.
Is Biocerta Precision Diagnostics, Inc. a public or private company?
Biocerta Precision Diagnostics, Inc. is a private company.
What is the current stock price of Biocerta Precision Diagnostics, Inc.?
Biocerta Precision Diagnostics, Inc. is a private company, so its shares have no public market price. Caplight tracks Biocerta Precision Diagnostics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biocerta Precision Diagnostics, Inc. worth (valuation)?
Valuation information for Biocerta Precision Diagnostics, Inc. is not publicly available.
Can I buy Biocerta Precision Diagnostics, Inc. stock?
Biocerta Precision Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biocerta Precision Diagnostics, Inc.'s last funding round?
Biocerta Precision Diagnostics, Inc.'s most recent funding round was Corporate Funding on December 17, 2025.
Who are the main investors in Biocerta Precision Diagnostics, Inc.?
Investor information for Biocerta Precision Diagnostics, Inc. is not publicly disclosed.
Will Biocerta Precision Diagnostics, Inc. IPO soon?
No public IPO plans have been announced for Biocerta Precision Diagnostics, Inc..
How can I track Biocerta Precision Diagnostics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Biocerta Precision Diagnostics, Inc.'s shares on secondary markets.